|
1
|
Thomas M, Yawn BP, Price D, Lund V, Mullol
J and Fokkens W; European Position Paper on Rhinosinusitis and
Nasal Polyps Group, : EPOS primary care guidelines: European
position paper on the primary care diagnosis and management of
rhinosinusitis and nasal polyps 2007-a summary. Prim Care Respir J.
17:79–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hedman J, Kaprio J, Poussa T and Nieminen
MM: Prevalence of asthma, aspirin intolerance, nasal polyposis and
chronic obstructive pulmonary disease in a population-based study.
Int J Epidemiol. 28:717–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang QP, Escudier E, Roudot-Thoraval F,
Abd-Al Samad I, Peynegre R and Coste A: Myofibroblast accumulation
induced by transforming growth factor-beta is involved in the
pathogenesis of nasal polyps. Laryngoscope. 107:926–931. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park IH, Park SJ, Cho JS, Moon YM, Kim TH,
Lee SH and Lee HM: Role of reactive oxygen species in transforming
growth factor beta1-induced alpha smooth-muscle actin and collagen
production in nasal polyp-derived fibroblasts. Int Arch Allergy
Immunol. 159:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park HH, Park IH, Cho JS, Lee YM and Lee
HM: The effect of macrolides on myofibroblast differentiation and
collagen production in nasal polyp-derived fibroblasts. Am J Rhinol
Allergy. 24:348–353. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shin JM, Park JH, Park IH and Lee HM:
Doxycycline inhibits TGF-β1-induced extracellular matrix production
in nasal polyp-derived fibroblasts. Int Forum Allergy Rhinol.
6:256–263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ledon JA, Savas J, Franca K, Chacon A and
Nouri K: Intralesional treatment for keloids and hypertrophic
scars: A review. Dermatol Surg. 39:1745–1757. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones CD, Guiot L, Samy M, Gorman M and
Tehrani H: The use of chemotherapeutics for the treatment of keloid
scars. Dermatol Reports. 7:58802015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hendricks T, Martens MF, Huyben CM and
Wobbes T: Inhibition of basal and TGF beta-induced fibroblast
collagen synthesis by antineoplastic agents. Implications for wound
healing. Br J Cancer. 67:545–550. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeowell HN, Marshall MK, Walker LC, Ha V
and Pinnell SR: Regulation of lysyl oxidase mRNA in dermal
fibroblasts from normal donors and patients with inherited
connective tissue disorders. Arch Biochem Biophys. 308:299–305.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wallach-Dayan SB, Izbicki G, Cohen PY,
Gerstl-Golan R, Fine A and Breuer R: Bleomycin initiates apoptosis
of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J
Physiol Lung Cell Mol Physiol. 290:L790–L796. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang R, Ibarra-Sunga O, Verlinski L, Pick
R and Uhal BD: Abrogation of bleomycin-induced epithelial apoptosis
and lung fibrosis by captopril or by a caspase inhibitor. Am J
Physiol Lung Cell Mol Physiol. 279:L143–L151. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Zou J, Li B, Ren X and Shi J:
Eosinophil apoptosis in nasal polyposis tissue after bleomycin A5
local injection. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 18:279–281.
2004.(In Chinese). PubMed/NCBI
|
|
14
|
Park IH, Um JY, Hong SM, Cho JS, Lee SH,
Lee SH and Lee HM: Metformin reduces TGF-β1-induced extracellular
matrix production in nasal polyp-derived fibroblasts. Otolaryngol
Head Neck Surg. 150:148–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharifi S, Barar J, Hejazi MS and Samadi
N: Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of
breast cancer cells to paclitaxel. Asian Pac J Cancer Prev.
15:8617–8622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsukui T, Ueha S, Abe J, Hashimoto S,
Shichino S, Shimaoka T, Shand FH, Arakawa Y, Oshima K, Hattori M,
et al: Qualitative rather than quantitative changes are hallmarks
of fibroblasts in bleomycin-induced pulmonary fibrosis. Am J
Pathol. 183:758–773. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XQ, Liu YK, Qing C and Lu SL: A
review of the effectiveness of antimitotic drug injections for
hypertrophic scars and keloids. Ann Plast Surg. 63:688–692. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Zhang H, Soledad-Conrad V, Zhuang J
and Uhal BD: Bleomycin-induced apoptosis of alveolar epithelial
cells requires angiotensin synthesis de novo. Am J Physiol Lung
Cell Mol Physiol. 284:L501–L507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bleackley RC and Heibein JA: Enzymatic
control of apoptosis. Nat Prod Rep. 18:431–440. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Budinger GR, Mutlu GM, Eisenbart J, Fuller
AC, Bellmeyer AA, Baker CM, Wilson M, Ridge K, Barrett TA, Lee VY
and Chandel NS: Proapoptotic Bid is required for pulmonary
fibrosis. Proc Natl Acad Sci USA. 103:pp. 4604–4609. 2006;
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kasper M and Barth K: Bleomycin and its
role in inducing apoptosis and senescence in lung cells-modulating
effects of caveolin-1. Curr Cancer Drug Targets. 9:341–353. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen YB, Aon MA, Hsu YT, Soane L, Teng X,
McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, et al: Bcl-×L
regulates mitochondrial energetics by stabilizing the inner
membrane potential. J Cell Biol. 195:263–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prenek L, Boldizsár F, Kugyelka R, Ugor E,
Berta G, Németh P and Berki T: The regulation of the mitochondrial
apoptotic pathway by glucocorticoid receptor in collaboration with
Bcl-2 family proteins in developing T cells. Apoptosis. 22:239–253.
2017. View Article : Google Scholar : PubMed/NCBI
|
